The authors searched PubMed, Scopus, MEDLINE, ScienceDirect, and ClinicalTrials.gov, and selected studies based on reports ...
In the third case, moderator Lisa J. Faia, MD presents her case of persistently active central retinal vein occlusion (CRVO), ...
Real-World Indian Data Confirms Safety of Lupin's Ranieyes for various Chorioretinal Vascular Disease Ranibizumab (Ranieyes) ...
Table 1. Summary of evidence: results of anti-vascular endothelial growth factor treatment on central retinal vein occlusion macular edema. n = 2 in second-year BRVO n = 3.5 in second-year CRVO ...
The dilemma still holds regarding treatment of the very ischemic central retinal vein occlusion subgroup with ME with profound visual loss. Combination therapy of anti-VEGF agents and a steroid ...
and Macular Oedema following Retinal Vein Occlusion (RVO). The CHMP's scientific assessment report forms the basis for the European Commission's decision to grant a central marketing authorization, ...
and Macular Oedema following Retinal Vein Occlusion (RVO). The CHMP's scientific assessment report forms the basis for the European Commission's decision to grant a central marketing authorization ...
nAMD is a subtype of AMD, characterized by a vision loss in the central zone ... degeneration (nAMD), macular oedema following retinal vein occlusion (RVO), diabetic macular oedema (DME) and ...
nAMD is a subtype of AMD, characterized by a vision loss in the central zone, and is a leading cause of ... related macular degeneration (nAMD), macular oedema following retinal vein occlusion (RVO), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback